A Randomised, Open-Label, Single-Centre, Phase I, Crossover Study to Evaluate the Effect of AZD6482, Compared With Clopidogrel, on Bleeding Time in Healthy Volunteers Receiving Low-Dose ASA.

Trial Profile

A Randomised, Open-Label, Single-Centre, Phase I, Crossover Study to Evaluate the Effect of AZD6482, Compared With Clopidogrel, on Bleeding Time in Healthy Volunteers Receiving Low-Dose ASA.

Completed
Phase of Trial: Phase I

Latest Information Update: 09 Dec 2009

At a glance

  • Drugs Aspirin; AZD 6482; Clopidogrel
  • Indications Acute coronary syndromes; Atherosclerosis; Ischaemic heart disorders; Myocardial infarction; Peripheral arterial occlusive disorders; Stroke; Thrombosis
  • Focus Pharmacodynamics
  • Sponsors AstraZeneca
  • Most Recent Events

    • 20 Aug 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 03 Mar 2009 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top